Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-25-005419
Filing Date
2025-04-24
Accepted
2025-04-24 16:20:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A elev-20241231xdefa14a.htm DEFA14A 14258
2 GRAPHIC elev-20241231xdefa14a_bg001.jpg GRAPHIC 149406
3 GRAPHIC elev-20241231xdefa14a_bg002.jpg GRAPHIC 111206
  Complete submission text file 0001558370-25-005419.txt   366987
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40523 | Film No.: 25867632
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)